24 June 2021
Latham & Watkins Advises Underwriters in Monte Rosa Therapeutics’ IPO
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Alison Haggerty Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Biagio Marino | Latham & Watkins LLP | Associate | capital markets | New York |
| Melange Gavin | Latham & Watkins LLP | Associate | capital markets | New York |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 222m (US$222.3 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Monte Rosa Therapeutics, Inc. (Issuer)